No Non-Inferiority, No Problem: FDA Advisory Committee Endorses Prevnar 13
This article was originally published in The Pink Sheet Daily
Executive Summary
Panel votes 10-1 to recommend next-generation pneumococcal vaccine for prevention of invasive disease, but says claim for further protection against otitis media should await post-market study data.